Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Amylase in blood, psychotropic agent effects
Analgesics headache after ECT managing behavioural and psychological symptoms of dementia opioid avoidance for patients on naltrexone opioid substitution treatment combination
angiotensin-converting enzyme (ACE) inhibitors, lithium interaction
angiotensin II receptor antagonists, lithium interaction
Anhedonia, stimulant use detoxification
anorexia nervosa (AN) 792-794 antidepressants co-morbid conditions monitoring when on oral electrolyte supplementation NICE guidelines psychological symptom treatment relapse prevention treating physical aspects weight restoration
antiamyloid therapy, Alzheimerâ™s disease treatment
Antibiotics psychiatric adverse effects safety in older patients/dementia
Anticholinergic adverse effects of antipsychotics
Anticholinergic burden
Anticholinergic burden, cognitive impairment
Anticholinergic Effect on Cognition (AEC) scale scores (Adapted from [6])
Anticoagulants, safety/use in older patients/dementia
Anticonvulsants benzodiazepine properties borderline personality disorder people with learning difficulties use in alcohol withdrawal management
Anti-dementia drugs Dementia use in renal impairment
Anti-dementia drugs in renal impairment
Antidepressants and degree of serotonin reuptake inhibition
Antidepressants and older people
Antidepressants in bariatric surgery
Antidepressants in breastfeeding
Antidepressants in hepatic impairment
Antidepressants in renal impairment
Antidepressants - swapping and stopping
Antidepressants
Antidepressant withdrawal at risk patients avoidance clinical relevance stopping switching time course treatment troubleshooting during tapering
Antiemetics, safety in older patients/dementia
Antihistamines driving impairment safety in older patients/dementia
Antihypertensives, safety/use in older patients/dementia
anti-inflammatory drugs, Alzheimerâ™s disease management
Antimalarials psychiatric adverse effects QT prolongation